ULISSE BIOMED SPA (UBM.MI) Stock Cash Flow
Europe • Euronext Milan • BIT:UBM • IT0005451213
0.8 EUR
0 (0%)
Last: Dec 8, 2025, 07:00 PM
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.30M | -5.94M | -2.47M | -1.31M | -603.60K | |||
| Depreciation Amortization | 3.03M | 2.92M | 2.50M | 319.60K | 247.70K | |||
| Change In Working Capital | -385.00K | -542.00K | 1.54M | 171.30K | 92.10K | |||
| Other non cash items | 3.50K | 0.00 | -153.80K | -153.70K | -131.00K | |||
| OPERATING CASH FLOW | -2.65M | -3.56M | -907.30K | -970.50K | -394.80K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -93.20K | -35.80K | -98.60K | -227.90K | -955.70K | |||
| Other Investing Activity | N/A | 6.10K | 0.00 | 0.00 | -2.30K | |||
| INVESTING CASH FLOW | -87.00K | -29.60K | -98.60K | -227.90K | -958.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 764.30K | 39.20K | 0.00 | 2.50K | 6.30M | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | 2.50K | 6.30M | |||
| Other Financing Activity | 1.81M | 2.26M | 0.00 | N/A | 0.00 | |||
| FINANCING CASH FLOW | 2.57M | 2.30M | 0.00 | 2.50K | 6.30M | |||
| CHANGE IN CASH | -164.20K | -1.28M | -1.01M | -1.20M | 4.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.65M | -3.56M | -907.30K | -970.50K | -394.80K | |||
| Capital Expenditure | -93.20K | -35.80K | -98.60K | -227.90K | -955.70K | |||
| FREE CASH FLOW | -2.74M | -3.59M | -1.01M | -1.20M | -1.35M | |||
All data in EUR